İ. ATAHAN Et Al. , "Zoledronic Acid With Either Standard or Reduced Dose Palliative Radiotherapy In The Management Of The Breast Cancer Patients With Bone Metastases: A Phase IV Randomized Study," 25th European Society for Therapeutic Radiology and Oncology (ESTRO) Meeting , Leipzing, Germany, pp.150, 2006
ATAHAN, İ. Et Al. 2006. Zoledronic Acid With Either Standard or Reduced Dose Palliative Radiotherapy In The Management Of The Breast Cancer Patients With Bone Metastases: A Phase IV Randomized Study. 25th European Society for Therapeutic Radiology and Oncology (ESTRO) Meeting , (Leipzing, Germany), 150.
ATAHAN, İ., YILDIZ, F., CENGİZ, M., KAPLAN, B., ÖZKAN, M., HAYDAROĞLU, A., ... ŞENGÖZ, M.(2006). Zoledronic Acid With Either Standard or Reduced Dose Palliative Radiotherapy In The Management Of The Breast Cancer Patients With Bone Metastases: A Phase IV Randomized Study . 25th European Society for Therapeutic Radiology and Oncology (ESTRO) Meeting (pp.150). Leipzing, Germany
ATAHAN, İ.L. Et Al. "Zoledronic Acid With Either Standard or Reduced Dose Palliative Radiotherapy In The Management Of The Breast Cancer Patients With Bone Metastases: A Phase IV Randomized Study," 25th European Society for Therapeutic Radiology and Oncology (ESTRO) Meeting, Leipzing, Germany, 2006
ATAHAN, İ.L. Et Al. "Zoledronic Acid With Either Standard or Reduced Dose Palliative Radiotherapy In The Management Of The Breast Cancer Patients With Bone Metastases: A Phase IV Randomized Study." 25th European Society for Therapeutic Radiology and Oncology (ESTRO) Meeting , Leipzing, Germany, pp.150, 2006
ATAHAN, İ. Et Al. (2006) . "Zoledronic Acid With Either Standard or Reduced Dose Palliative Radiotherapy In The Management Of The Breast Cancer Patients With Bone Metastases: A Phase IV Randomized Study." 25th European Society for Therapeutic Radiology and Oncology (ESTRO) Meeting , Leipzing, Germany, p.150.
@conferencepaper{conferencepaper, author={İ.L. ATAHAN Et Al. }, title={Zoledronic Acid With Either Standard or Reduced Dose Palliative Radiotherapy In The Management Of The Breast Cancer Patients With Bone Metastases: A Phase IV Randomized Study}, congress name={25th European Society for Therapeutic Radiology and Oncology (ESTRO) Meeting}, city={Leipzing}, country={Germany}, year={2006}, pages={150} }